Table 1.
PULSESMART participant characteristics
| Characteristics | AF (n=98) |
PAC (n=15) |
PVC (n=15) |
Sinus Rhythm (n=91)* |
|---|---|---|---|---|
| Age, years, M (SD) | 65.9 (12.2) | 73.1 (5.9) | 62.8 (13.8) | 66 (11.9) |
| Sex, male, n (%) | 70 (71.4) | 11 (73.3) | 9 (60) | 63 (69.2) |
| White Race, n (%) | 91 (92.9) | 14 (93.3) | 13 (86.7) | 86 (94.5) |
| Body Mass Index, kg/m2, M (SD) | 31.6 (8.5) | 27.7 (8.4) | 32.1 (8.6) | 31.6 (8.1) |
| Medical Characteristics | ||||
| Hypertension | 70 (71.4) | 14 (93.3) | 13 (86.7) | 63 (69.2) |
| Hyperlipidemia | 59 (60.2) | 10 (66.7) | 10 (66.7) | 56 (61.5) |
| Current smoking | 8 (8.2) | 2 (13.3) | 4 (26.7) | 7 (7.7) |
| Diabetes mellitus | 26 (26.5) | 6 (40) | 4 (26.7) | 25 (27.5) |
| Coronary artery disease | 24 (24.5) | 4 (26.7) | 4 (26.7) | 23 (25.3) |
| Congestive heart failure | 27 (27.6) | 7 (46.7) | 8 (53.3) | 22 (24.2) |
| Sleep Apnea | 17 (17.3) | 2 (13.3) | 3 (20) | 14 (15.4) |
| Stroke | 10 (10.2) | 4 (26.7) | 3 (20) | 8 (8.8) |
| Medical treatment | ||||
| Beta-blocker | 64 (65.3) | 8 (53.3) | 9 (60) | 61 (67) |
| Calcium channel blocker | 27 (27.6) | 5 (33.3) | 1 (6.7) | 23 (25.3) |
| Anti-arrhythmic drug | ||||
| Class I | 8 (8.2) | 0 (0) | 0 (0) | 8 (8.8) |
| Class III | 29 (29.6) | 2 (13.3) | 2 (13.3) | 26 (28.6) |
| Digoxin | 7 (7.1) | 1 (6.7) | 1 (6.7) | 5 (5.5) |
Legend. AF = atrial fibrillation. PAC = premature atrial contraction. PVC = premature ventricular contraction.
*
91 of the 98 participants with AF were successfully converted to sinus rhythm.